E-Mail Updates

Click here to join
our Electronic Communications.

Listen to our latest webcast
“Immutep to Present at Ladenburg Thalmann 2018 Healthcare Conference ”
from October 2nd, 2018

Investors & Media

Whats new.

Press releases

Press releases.

Notice of Annual General Meeting/Proxy Form

October 12th 2018
press releases

Immutep Announces Presentations at Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting

October 2nd 2018
press releases

Immutep to Present at Ladenburg Thalmann 2018 Healthcare Conference

September 26th 2018
press releases

Investor updates

Investor updates.

Investor Update - June 2018

June 19th 2018
investor updates

Investor Update - December 2017

December 21st 2017
investor updates

Investor Update Edition 21

October 1st 2017
investor updates

Analyst reports

Analyst reports.

LifeSci Capital Initiates Coverage of Immutep (IMMP)

October 18th 2018
analyst reports

B Riley FBR - Leading the LAG-3 Immunotherapy Charge into Immuno-oncology and Autoimmune Disease – Initiating Coverage

September 28th 2018
analyst reports

goetzpartners securities - Key takeaways from investor meetings in London

This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clients.

September 27th 2018
analyst reports